Companies / Rhythm Pharmaceuticals, Inc. / Activity
Activity — Rhythm Pharmaceuticals, Inc.
109 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | Good Jennifer L Director | Grant | Stock Option (right to buy) | — | +4K | 3,691 <0.01% of shares | low |
| Jun 23, 2026 | Good Jennifer L Director | Exercise | Restricted Stock Units | — | -5K -100.00% | 0 0.00% of shares | low |
| Jun 23, 2026 | Good Jennifer L Director | Exercise | Common Stock | — | +5K +67.31% | 11,712 0.02% of shares | low |
| Jun 24, 2026 | McGirr David W J Director | Grant | Restricted Stock Units | — | +2K | 2,324 <0.01% of shares | low |
| Jun 24, 2026 | McGirr David W J Director | Grant | Stock Option (right to buy) | — | +4K | 3,691 <0.01% of shares | low |
| Jun 23, 2026 | McGirr David W J Director | Exercise | Restricted Stock Units | — | -5K -100.00% | 0 0.00% of shares | low |
| Jun 23, 2026 | McGirr David W J Director | Exercise | Common Stock | — | +5K +67.31% | 11,712 0.02% of shares | low |
| Feb 11, 2026 | Lee Jennifer Kayden Executive | Grant | Stock Options (Right to Buy) | — | +33K | 32,500 0.05% of shares | low |
| Feb 11, 2026 | Lee Jennifer Kayden Executive | Grant | Restricted Stock Units | — | +22K | 21,650 0.03% of shares | low |
| Feb 1, 2026 | Lee Jennifer Kayden Executive | Exercise | Restricted Stock Units | — | -9K -25.00% | 27,487 0.04% of shares | low |
| Feb 1, 2026 | Lee Jennifer Kayden Executive | Exercise | Restricted Stock Units | — | -6K -33.33% | 11,000 0.02% of shares | low |
| Feb 1, 2026 | Lee Jennifer Kayden Executive | Exercise | Restricted Stock Units | — | -5K -50.00% | 4,512 <0.01% of shares | low |
| Feb 1, 2026 | Lee Jennifer Kayden Executive | Exercise | Restricted Stock Units | — | -3K -100.00% | 0 0.00% of shares | low |
| Feb 1, 2026 | Lee Jennifer Kayden Executive | Exercise | Common Stock | — | +23K +386.00% | 28,470 0.04% of shares | low |
| Mar 2, 2026 | Mazabraud Yann Executive | Grant | Stock Options (Right to Buy) | — | +35K | 35,000 0.05% of shares | low |
| Feb 14, 2026 | Mazabraud Yann Executive | Exercise | Restricted Stock Units | — | -10K -25.00% | 30,000 0.04% of shares | low |
| Feb 14, 2026 | Mazabraud Yann Executive | Exercise | Common Stock | — | +10K +23.17% | 53,155 0.08% of shares | low |
| Feb 11, 2026 | Mazabraud Yann Executive | Grant | Restricted Stock Units | — | +23K | 23,350 0.03% of shares | low |
| Feb 1, 2026 | Mazabraud Yann Executive | Exercise | Restricted Stock Units | — | -6K -33.33% | 11,000 0.02% of shares | low |
| Feb 1, 2026 | Mazabraud Yann Executive | Exercise | Common Stock | — | +6K +14.61% | 43,155 0.06% of shares | low |
| Mar 4, 2026 | German Christopher Paul Executive | Exercise | Stock Options (Right to Buy) | — | -2K -28.68% | 3,731 <0.01% of shares | low |
| Mar 1, 2026 | German Christopher Paul Executive | Exercise | Restricted Stock Units | — | -1K -50.00% | 1,162 <0.01% of shares | low |
| Mar 1, 2026 | German Christopher Paul Executive | Exercise | Common Stock | — | +1K +33.85% | 4,595 <0.01% of shares | low |
| Mar 2, 2026 | Smith Hunter C Executive | Exercise | Stock Options (Right to Buy) | — | -6K -6.26% | 91,401 0.13% of shares | low |
| Feb 11, 2026 | Shulman Joseph Executive | Grant | Stock Options (Right to Buy) | — | +23K | 22,500 0.03% of shares | low |
| Feb 11, 2026 | Shulman Joseph Executive | Grant | Restricted Stock Units | — | +15K | 15,000 0.02% of shares | low |
| Feb 11, 2026 | Meeker David P CEO | Grant | Stock Options (Right to Buy) | — | +108K | 107,850 0.16% of shares | low |
| Feb 11, 2026 | Meeker David P CEO | Grant | Restricted Stock Units | — | +72K | 71,900 0.10% of shares | low |
| Feb 11, 2026 | German Christopher Paul Executive | Grant | Restricted Stock Units | — | +5K | 5,215 <0.01% of shares | low |
| Feb 11, 2026 | Garfield Alastair Executive | Grant | Stock Options (Right to Buy) | — | +25K | 25,000 0.04% of shares | low |
| Feb 11, 2026 | Garfield Alastair Executive | Grant | Restricted Stock Units | — | +17K | 16,650 0.02% of shares | low |
| Feb 11, 2026 | Cramer Pamela J. Executive | Grant | Stock Options (Right to Buy) | — | +18K | 17,500 0.03% of shares | low |
| Feb 11, 2026 | Cramer Pamela J. Executive | Grant | Restricted Stock Units | — | +12K | 11,650 0.02% of shares | low |
| Feb 11, 2026 | Smith Hunter C Executive | Grant | Stock Options (Right to Buy) | — | +38K | 37,500 0.05% of shares | low |
| Feb 11, 2026 | Smith Hunter C Executive | Grant | Restricted Stock Units | — | +25K | 25,000 0.04% of shares | low |
| Feb 1, 2026 | Smith Hunter C Executive | Exercise | Restricted Stock Units | — | -10K -25.00% | 31,237 0.05% of shares | low |
| Feb 1, 2026 | Smith Hunter C Executive | Exercise | Restricted Stock Units | — | -7K -33.33% | 13,200 0.02% of shares | low |
| Feb 1, 2026 | Smith Hunter C Executive | Exercise | Restricted Stock Units | — | -5K -50.00% | 4,925 <0.01% of shares | low |
| Feb 1, 2026 | Smith Hunter C Executive | Exercise | Restricted Stock Units | — | -4K -100.00% | 0 0.00% of shares | low |
| Feb 1, 2026 | Smith Hunter C Executive | Exercise | Common Stock | — | +26K +22.24% | 142,915 0.21% of shares | low |
| Feb 1, 2026 | Shulman Joseph Executive | Exercise | Restricted Stock Units | — | -6K -25.00% | 18,750 0.03% of shares | low |
| Feb 1, 2026 | Shulman Joseph Executive | Exercise | Restricted Stock Units | — | -4K -33.33% | 8,250 0.01% of shares | low |
| Feb 1, 2026 | Shulman Joseph Executive | Exercise | Restricted Stock Units | — | -4K -50.00% | 3,937 <0.01% of shares | low |
| Feb 1, 2026 | Shulman Joseph Executive | Exercise | Restricted Stock Units | — | -3K -100.00% | 0 0.00% of shares | low |
| Feb 1, 2026 | Shulman Joseph Executive | Exercise | Common Stock | — | +17K +199.41% | 25,477 0.04% of shares | low |
| Feb 1, 2026 | Meeker David P CEO | Exercise | Restricted Stock Units | — | -33K -25.00% | 100,012 0.15% of shares | low |
| Feb 1, 2026 | Meeker David P CEO | Exercise | Restricted Stock Units | — | -21K -33.33% | 42,500 0.06% of shares | low |
| Feb 1, 2026 | Meeker David P CEO | Exercise | Restricted Stock Units | — | -14K -50.00% | 14,125 0.02% of shares | low |
| Feb 1, 2026 | Meeker David P CEO | Exercise | Common Stock | — | +69K +34.05% | 270,538 0.39% of shares | low |
| Feb 1, 2026 | German Christopher Paul Executive | Exercise | Restricted Stock Units | — | -2K -25.01% | 5,418 <0.01% of shares | low |